Home Ascletis Pharma (01672.HK): GIC Raises Stake to 7% — ASC30 US Phase II Enrollment Complete

Ascletis Pharma (01672.HK): GIC Raises Stake to 7% — ASC30 US Phase II Enrollment Complete

May 21, 2026 10:57 CST Updated 11:21